Thermo Fisher Scientific Pre-Tax Income increased by 7.0% to $1.73B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.0%, from $1.62B to $1.73B. Over 3 years (FY 2021 to FY 2024), Pre-Tax Income shows a downward trend with a -7.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
This provides a view of profitability that is not skewed by varying tax rates or one-time tax credits.
A company's profits before the deduction of corporate income tax. It combines operating performance with non-operating f...
Used to compare companies across different tax jurisdictions to see who generates more raw profit.
is_income_before_tax| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.05B | $2.17B | $1.87B | $2.54B | $1.92B | $1.60B | $1.78B | $1.36B | $1.43B | $1.77B | $1.74B | $1.59B | $1.77B | $1.74B | $1.94B | $1.62B | $1.73B |
| QoQ Change | — | +6.2% | -14.0% | +36.0% | -24.5% | -16.5% | +11.0% | -23.3% | +4.9% | +23.4% | -1.4% | -8.7% | +11.1% | -1.3% | +11.4% | -16.5% | +7.0% |
| YoY Change | — | — | — | — | -6.4% | -26.3% | -4.9% | -46.3% | -25.4% | +10.2% | -2.1% | +16.6% | +23.4% | -1.3% | +11.6% | +2.0% | +7.0% |